Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$592K Buy
4,071
+1,337
+49% +$185K 0.05% 112
2026
Q2
$351K Buy
2,734
+29
+1% +$3.39K 0.03% 131
2026
Q1
$285K Hold
2,705
– – 0.03% 142
2025
Q4
$285K Buy
2,705
+37
+1% +$3.47K 0.03% 155
2025
Q3
$211K Buy
2,668
+19
+0.7% +$1.56K 0.02% 142
2025
Q2
$238K Buy
2,649
+15
+0.6% +$1.19K 0.03% 147
2025
Q1
$262K Buy
2,634
+14
+0.5% +$1.31K 0.03% 132
2024
Q4
$298K Buy
2,620
+11
+0.4% +$1.13K 0.04% 122
2024
Q3
$323K Buy
2,609
+11
+0.4% +$1.31K 0.04% 100
2024
Q2
$343K Hold
2,598
– – 0.05% 98
2024
Q1
$343K Buy
2,598
+11
+0.4% +$1.36K 0.05% 99
2023
Q4
$282K Buy
2,587
+21
+0.8% +$2.18K 0.04% 113
2023
Q3
$296K Hold
2,566
– – 0.05% 100
2023
Q2
$296K Buy
2,566
+20
+0.8% +$2.27K 0.05% 105
2023
Q1
$283K Buy
+2,546
New +$275K 0.05% 102
2022
Q4
– Sell
-2,534
Closed -$218K – 118
2022
Q3
$218K Buy
2,534
+11
+0.4% +$982 0.04% 98
2022
Q2
$230K Buy
+2,523
New +$224K 0.04% 94
2021
Q1
– Sell
-2,594
Closed -$202K – 88
2020
Q4
$202K Buy
+2,594
New +$198K 0.04% 77

Other funds holding MRK

KWB Wealth's MRK Position: Q3 2026 in Review

KWB Wealth increased its Merck (MRK) stake by 49% in Q3 2026, buying an estimated $185K and bringing the position to 4,071 shares worth $592K. The position accounts for 0.05% of the portfolio, ranked #112.

KWB Wealth first reported a position in MRK in Q4 2020 and has held it in 18 quarters since. 1,277 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • KWB Wealth held 4,071 shares of Merck worth $592K as of Q3 2026.
  • KWB Wealth bought 1,337 Merck shares in Q3 2026, an estimated $185K.
  • Merck made up 0.05% of KWB Wealth's portfolio in Q3 2026, its #112 holding.
  • KWB Wealth first reported a position in Merck in Q4 2020 and has held it in 18 quarters since.
  • 1,277 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on KWB Wealth's 13F filing for Q3 2026, filed 16 Oct 2026.